RARE
NASDAQ · Biotechnology
Ultragenyx Pharmaceutical In
$25.02
+0.11 (+0.44%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
+4.77%
1Y
-10.10%
YTD
+6.02%
Open$24.92
Previous Close$24.91
Day High$25.40
Day Low$24.01
52W High$39.89
52W Low$18.29
Volume—
Avg Volume1.86M
Market Cap2.54B
P/E Ratio—
EPS$-6.10
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$26.56
Below
SMA 200
$31.06
Below
RSI (14)
37.4
Neutral
Trend
Death Cross
Bearish
Analyst Ratings
Strong Buy
25 analysts
Price Target
+197.5% upside
Current
$25.02
$25.02
Target
$74.44
$74.44
$68.49
$74.44 avg
$103.74
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 644.88M | 525.11M | 933.24M |
| Net Income | -550,970,131 | -403,772,590 | 54.30M |
| Profit Margin | -85.4% | -81.2% | 5.8% |
| EBITDA | -504,977,220 | -390,626,462 | 81.20M |
| Free Cash Flow | — | — | 84.57M |
| Rev Growth | +22.8% | +22.8% | -2.9% |
| Debt/Equity | 3.41 | 3.41 | 0.13 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $244.33 | -0.76% | 122.9 | 446.67B |
| AMGN | Amgen Inc | $403.48 | -1.07% | 26.5 | 206.48B |
| GILD | Gilead Sciences Inc | $129.97 | -1.36% | 17.6 | 161.72B |
| VRTX | Vertex Pharmaceuticals Inc | $484.53 | -0.06% | 27.8 | 120.52B |
| REGN | Regeneron Pharmaceuticals | $767.54 | -0.14% | 17.5 | 77.36B |
| ALNY | Alnylam Pharmaceuticals Inc | $217.83 | -4.76% | 47.7 | 27.52B |